Wen Cheng

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 10

Top Topics

Transforming Growth Factor

Nitric Oxide Synthase

Top Venues

CNS neuroscience & therapeutics

Communications biology

Journal of translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yuhe Li, Xiufang Ren, Wei Gao, Ruikai Cai, Jianqi Wu, Tianqi Liu, Xin Chen, Daoming Jiang, Chong Chen, Quan Chen, An-Hua Wu, Wen Cheng
The biological behavior and clinical outcome of pituitary adenoma are affected by the microenvironment. CNS neuroscience & therapeutics 30 (5) (2024)
Yuhe Li, Xiufang Ren, Wei Gao, Ruikai Cai, Jianqi Wu, Tianqi Liu, Xin Chen, Daoming Jiang, Chong Chen, Quan Chen, An-Hua Wu, Wen Cheng
The biological behavior and clinical outcome of pituitary adenoma are affected by the microenvironment. CNS neuroscience & therapeutics 30 (5) (2024)
Yuhe Li, Xiufang Ren, Wei Gao, Ruikai Cai, Jianqi Wu, Tianqi Liu, Xin Chen, Daoming Jiang, Chong Chen, Quan Chen, An-Hua Wu, Wen Cheng
The biological behavior and clinical outcome of pituitary adenoma are affected by the microenvironment. CNS neuroscience & therapeutics 30 (5) (2024)
Yuhe Li, Xiufang Ren, Wei Gao, Ruikai Cai, Jianqi Wu, Tianqi Liu, Xin Chen, Daoming Jiang, Chong Chen, Quan Chen, An-Hua Wu, Wen Cheng
The biological behavior and clinical outcome of pituitary adenoma are affected by the microenvironment. CNS neuroscience & therapeutics 30 (5) (2024)
Shuai Shen, Xing Liu, Qing Guo, Qingyu Liang, Jianqi Wu, Gefei Guan, Cunyi Zou, Chen Zhu, Zihao Yan, Tianqi Liu, Ling Chen, Peng Cheng, Wen Cheng, An-Hua Wu
Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate. Communications biology 6 (1) (2023)
Shuai Shen, Xing Liu, Qing Guo, Qingyu Liang, Jianqi Wu, Gefei Guan, Cunyi Zou, Chen Zhu, Zihao Yan, Tianqi Liu, Ling Chen, Peng Cheng, Wen Cheng, An-Hua Wu
Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate. Communications biology 6 (1) (2023)
Shuai Shen, Xing Liu, Qing Guo, Qingyu Liang, Jianqi Wu, Gefei Guan, Cunyi Zou, Chen Zhu, Zihao Yan, Tianqi Liu, Ling Chen, Peng Cheng, Wen Cheng, An-Hua Wu
Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate. Communications biology 6 (1) (2023)
Shuai Shen, Xing Liu, Qing Guo, Qingyu Liang, Jianqi Wu, Gefei Guan, Cunyi Zou, Chen Zhu, Zihao Yan, Tianqi Liu, Ling Chen, Peng Cheng, Wen Cheng, An-Hua Wu
Tumor microenvironment remodeling plus immunotherapy could be used in mesenchymal-like tumor with high tumor residual and drug resistant rate. Communications biology 6 (1) (2023)
Jianqi Wu, Shuai Shen, Tianqi Liu, Xiufang Ren, Chen Zhu, Qingyu Liang, Xiao Cui, Ling Chen, Peng Cheng, Wen Cheng, An-Hua Wu
Chemerin enhances mesenchymal features of glioblastoma by establishing autocrine and paracrine networks in a CMKLR1-dependent manner. Oncogene 41 (21) (2022)
Qingyu Liang, Gefei Guan, Xue Li, Chunmi Wei, Jianqi Wu, Peng Cheng, Anhua Wu, Wen Cheng
Profiling pro-neural to mesenchymal transition identifies a lncRNA signature in glioma. Journal of translational medicine 18 (1) (2020)